Oncology Central

Nanomedicine for the treatment of triple-negative breast cancer


Breast cancer is one of the leading causes of death. Breast cancer is generally classified based on the receptors overexpressed on the cell membrane, which include hormone receptors such as progesterone (PR) and estrogen (ER), and HER2. Triple-negative breast cancer (TNBC) is a type of cancer that lacks any of these three types of receptor proteins (ER/PR/HER2).

To view restricted content, please:

Leave A Comment